Form 4: Entera Bio Director Exercises Warrants, Acquires Shares

Director Gerald M. Lieberman exercised warrants to acquire 23,952 ordinary shares of Entera Bio Ltd. at a price of $1 per share on April 1, 2025.

Summary

• On April 1, 2025, Gerald M. Lieberman, a director of Entera Bio Ltd., exercised warrants to acquire 23,952 ordinary shares at a price of $1 per share.
• Following the transaction, Lieberman directly owns 300,160 ordinary shares.
• He also has indirect ownership of 6,200 ordinary shares through a trust for his grandchild, where his spouse is the trustee.
• Lieberman disclaims beneficial ownership of the securities held by the trust, except to the extent of his pecuniary interest.
• He also owns 28,509 warrants.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The warrant exercise itself could be seen as a positive signal, but the overall impact is likely minimal.

Management Comments

• The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Industry Context

This is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company directors.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence due to the director's increased investment in the company.

Key Dates

Keywords

Entera Bio Ltd., Director, Form 4, Warrant Exercise, Share Acquisition, Beneficial Ownership, ENTX, Gerald M. Lieberman